New weekly fertility injections work as well as daily

New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane systematic review and found no difference in pregnancies or serious side effects between the two regimens.

Women undergoing are usually given daily injections of follicle stimulating hormone (FSH) to increase the number of eggs that their ovaries release each month. In in vitro (IVF) and (ICSI), the eggs are then removed and fertilised outside the body. Daily hormone injections can be painful and stressful but a new longer-lasting FSH, known as corifollitropin alfa, has recently been introduced. One injection of this longer-lasting hormone can replace the first seven days of FSH injections required in the standard .

The researchers included data from four trials involving 2,335 people in their review. They show that women given medium doses of the new long-lasting hormone on a weekly basis are equally likely to become pregnant and are no more likely to have a miscarriage or than those receiving daily FSH injections.

"These results show that the new long-acting injections are a safe treatment option and equally effective in medium doses compared to the standard daily injections," said Jan Kremer, one of the authors of the review based at the Radboud University Nijmegen Medical Center in Nijmegen, Netherlands.

However, there is currently limited information about with long-lasting FSH. "One of the main reasons weekly injections are considered preferable to daily injections is that they are more patient friendly," said Kremer. "So are couples undergoing fertility treatment happier with weekly injections? We would like to see research addressing this question."

Further research is also needed to establish whether long-acting injections are as effective in women who respond poorly to fertility hormones and those who 'hyperrespond', meaning they produce higher than expected numbers of eggs.

More information: Pouwer AW, Farquhar C, Kremer JAM. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD009577. DOI: 10.1002/14651858.CD009577.pub2

add to favorites email to friend print save as pdf

Related Stories

Researchers develop long-lasting growth hormone

Sep 04, 2007

Researchers at the University of Sheffield have developed a long-acting growth hormone for use in human therapy. The new discovery could mean that children and adults with growth hormone disorders will not have to have injections ...

BPA lowers male fertility: report

Jun 06, 2011

Daily exposure to a chemical that is prevalent in the human environment, bisphenol A (BPA), causes lowered fertility in male mice, according to the results of a new study that will be presented Saturday at The Endocrine Society's ...

Recommended for you

Majority of women report sexual dysfunction after childbirth

Nov 27, 2014

Many women notice that their sexual health changes after childbirth, according to researchers from Loyola University Chicago. Loyola researchers have a study under way to determine the extent to which pelvic pain may be related ...

Is egg freezing an empowering option for women?

Nov 17, 2014

Katie Hammond, a PhD candidate in the Department of Sociology researching the experience of egg donation in Canada, discusses the recent decision by tech giants Facebook and Apple to offer egg freezing to ...

Peripheral nerve blocks OK for migraines in pregnancy

Nov 14, 2014

(HealthDay)—For migraines that do not respond to medications, peripheral nerve blocks may be a treatment option in pregnant women, according to research published online Nov. 5 in Obstetrics & Gynecology.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.